NEPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nephros Inc (NEPH) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are mixed, with bearish moving averages and no clear bullish momentum. The financial performance shows revenue growth but significant declines in net income, EPS, and gross margin, which are concerning for long-term growth. There are no recent news catalysts, analyst ratings, or significant insider or hedge fund activity to support a buy decision. Given the lack of strong positive signals and the investor's preference for long-term investments, holding off on buying NEPH is recommended.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 34.524, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 2.979, with key support at 2.81 and resistance at 3.147. Overall, the technical indicators do not suggest a strong buy signal.
Revenue increased by 22.20% YoY in Q4 2025, showing some growth potential.
Net income dropped by -82.23% YoY, EPS declined by -66.67%, and gross margin fell by -8.50% YoY. No recent news or significant trading trends from insiders or hedge funds. No recent congress trading data.
In Q4 2025, revenue increased by 22.20% YoY to $4,729,000. However, net income dropped significantly by -82.23% YoY to $62,000. EPS declined by -66.67% YoY to 0.01, and gross margin fell by -8.50% YoY to 57.71%. The financial performance shows revenue growth but significant profitability challenges.
No analyst ratings or price target changes available.
